Botox shot may ease thumb arthritis pain for months

NCT ID NCT03187626

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether a single ultrasound-guided injection of Botox into the thumb joint, combined with a splint, can reduce pain in people with base-of-thumb osteoarthritis. Sixty adults with moderate to severe pain received either Botox or a saline placebo injection. The main goal was to see if pain improved three months later.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
botulinum toxin A (Botox)
What this could lead to
If it works, this could offer a new, non-surgical option to ease thumb arthritis pain for several months.
What could go wrong
This is a small pilot study, so results may not apply to everyone. Pain relief may be short-lived or no better than a placebo injection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2/3

Runs two stages together: whether the treatment works, then large-scale confirmation.

Participants

60 people

The number who actually took part.

Started

Nov 2018

Finished

Apr 2021

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years old * Pain intensity on a self-administered 11-point pain numeric rating scale ≥ 30 * Pain involving the base-of-thumb * X-ray evidence of base-of-thumb osteoarthritis with at least 2 of the 4 following items involving the trapeziometacarpal joint : osteophytes, joint space narrowing, subchondral bone sclerosis or subchondral cysts * 1990 American College of Rheumatology classification criteria for hand osteoarthritis adapted to base-of-thumb osteoarthritis * Medical examination * Written consent * Health insurance * For women of childbearing age, a negative urinary pregnancy test Exclusion Criteria: * History of thumb surgery * History of inflammatory or crystal-associated rheumatic disease * Neurological disorders involving the hands other than carpien canal syndrom * Collagen disorders involving the hands : Dupuytren, Marfan or Ehlers-Danlos diseases * Osteoarthritis predominating at the scaphotrapezial joint on X-Ray * Hand or wrist trauma ≤ 2 months * Hand or wrist intra-articular injections ≤ 2 months * Contra-indication to botulinum toxin A injection or to splinting * Cognitive or behavioral disorders making the assessment impossible * Participant unable to speak, read and write french * Bilateral BTOA without predominant symptomatic side * Pregnancy and breast feeding * Persons referred to in Articles L 1121-5; 6; 8; 9 of the Public Health Code (protected minors or adults, guardianship or trusteeship, etc.) * Patient with epilepsy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Base-of-thumb osteoarthritis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Assistance Publique - Hôpitaux de Paris, Service de Rééducation et de Réadaptation de l'Appareil Locomoteur et des Pathologies du Rachis, Hôpital Cochin

    Paris, Paris, 75014, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.